Healthcare — Biogen and Eli Lilly Announce Major Acquisitions; Healthcare Industry Sees Consolidation Wave

Healthcare · 2026-03-31

Today marks a significant shift in both the pharmaceutical landscape and healthcare access dynamics. Two major acquisitions totaling $11.9B - Biogen's purchase of Apellis and Eli Lilly's acquisition of Centessa - signal aggressive expansion in immunology and rare disease treatments. Meanwhile, the intersection of policy and healthcare economics is creating new pressure points, with states…